Search by Drug Name or NDC

    NDC 00115-1687-74 Budesonide Inhalation 0.25 mg/2mL Details

    Budesonide Inhalation 0.25 mg/2mL

    Budesonide Inhalation is a RESPIRATORY (INHALATION) SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals of New York LLC. The primary component is BUDESONIDE.

    Product Information

    NDC 00115-1687
    Product ID 0115-1687_2404cb3e-b023-4709-a32e-3da5d7db731b
    Associated GPIs 44400015001830
    GCN Sequence Number 046525
    GCN Sequence Number Description budesonide AMPUL-NEB 0.25MG/2ML INHALATION
    HIC3 B6M
    HIC3 Description GLUCOCORTICOIDS, ORALLY INHALED
    GCN 17957
    HICL Sequence Number 006545
    HICL Sequence Number Description BUDESONIDE
    Brand/Generic Generic
    Proprietary Name Budesonide Inhalation
    Proprietary Name Suffix n/a
    Non-Proprietary Name Budesonide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SUSPENSION
    Route RESPIRATORY (INHALATION)
    Active Ingredient Strength 0.25
    Active Ingredient Units mg/2mL
    Substance Name BUDESONIDE
    Labeler Name Amneal Pharmaceuticals of New York LLC
    Pharmaceutical Class Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078404
    Listing Certified Through 2024-12-31

    Package

    NDC 00115-1687-74 (00115168774)

    NDC Package Code 0115-1687-74
    Billing NDC 00115168774
    Package 6 POUCH in 1 CARTON (0115-1687-74) / 5 VIAL in 1 POUCH (0115-1687-76) / 2 mL in 1 VIAL
    Marketing Start Date 2016-08-04
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 1.04496
    Pricing Unit ML
    Effective Date 2024-02-21
    NDC Description BUDESONIDE 0.25 MG/2 ML SUSP
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis